Israel Hodish

1.2k total citations
36 papers, 943 citations indexed

About

Israel Hodish is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Israel Hodish has authored 36 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Israel Hodish's work include Diabetes Management and Research (16 papers), Diabetes Treatment and Management (16 papers) and Pancreatic function and diabetes (9 papers). Israel Hodish is often cited by papers focused on Diabetes Management and Research (16 papers), Diabetes Treatment and Management (16 papers) and Pancreatic function and diabetes (9 papers). Israel Hodish collaborates with scholars based in United States, Israel and Germany. Israel Hodish's co-authors include Ming Liu, Peter Arvan, Christopher J. Rhodes, Gautam Rajpal, Leena Haataja, Roberto Lara‐Lemus, J. J. Wright, Ariel L. Barkan, Dennis Larkin and Richard M. Bergenstal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Israel Hodish

36 papers receiving 927 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Israel Hodish United States 14 425 415 288 276 234 36 943
Kathleen Waugh United States 16 358 0.8× 276 0.7× 390 1.4× 146 0.5× 28 0.1× 40 709
F. Sodoyez‐Goffaux Belgium 18 445 1.0× 409 1.0× 335 1.2× 253 0.9× 27 0.1× 48 901
Ryosuke Misawa United States 15 622 1.5× 280 0.7× 286 1.0× 215 0.8× 22 0.1× 42 837
Yukiko Kawasaki Japan 14 288 0.7× 329 0.8× 99 0.3× 209 0.8× 17 0.1× 36 713
Julie Méthot Canada 11 199 0.5× 226 0.5× 424 1.5× 373 1.4× 48 0.2× 29 879
Eiji Ohmura Japan 15 90 0.2× 285 0.7× 86 0.3× 336 1.2× 49 0.2× 29 733
Nadia Tinto Italy 15 250 0.6× 80 0.2× 194 0.7× 261 0.9× 33 0.1× 35 685
M. Dreyer Germany 14 171 0.4× 267 0.6× 127 0.4× 189 0.7× 37 0.2× 60 569
Amanda L. Posgai United States 21 645 1.5× 506 1.2× 792 2.8× 171 0.6× 21 0.1× 60 1.3k
C. M. Hoogerbrugge Netherlands 16 68 0.2× 360 0.9× 133 0.5× 254 0.9× 58 0.2× 29 632

Countries citing papers authored by Israel Hodish

Since Specialization
Citations

This map shows the geographic impact of Israel Hodish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Israel Hodish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Israel Hodish more than expected).

Fields of papers citing papers by Israel Hodish

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Israel Hodish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Israel Hodish. The network helps show where Israel Hodish may publish in the future.

Co-authorship network of co-authors of Israel Hodish

This figure shows the co-authorship network connecting the top 25 collaborators of Israel Hodish. A scholar is included among the top collaborators of Israel Hodish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Israel Hodish. Israel Hodish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Warren, Mark, et al.. (2024). A Scalable Application of Artificial Intelligence-Driven Insulin Titration Program to Transform Type 2 Diabetes Management. Diabetes Technology & Therapeutics. 26(8). 556–565. 4 indexed citations
2.
Harper, Roy, et al.. (2022). Challenging the 50‐50 rule for the basal‐bolus insulin ratio in patients with type 2 diabetes who maintain stable glycaemic control. Diabetes Obesity and Metabolism. 25(2). 581–585. 4 indexed citations
3.
Hodish, Israel. (2019). For debate; pharmacological priorities in advanced type 2 diabetes. Journal of Diabetes and its Complications. 34(5). 107510–107510. 2 indexed citations
4.
Hodish, Israel. (2018). Insulin therapy, weight gain and prognosis. Diabetes Obesity and Metabolism. 20(9). 2085–2092. 33 indexed citations
5.
Harper, Roy, et al.. (2018). Temporary Reductions in Insulin Requirements Are Associated with Hypoglycemia in Type 2 Diabetes. Diabetes Technology & Therapeutics. 20(12). 817–824. 4 indexed citations
6.
Hodish, Israel, et al.. (2018). Digitally Enhanced Insulin Therapy—A Multicenter Clinical Trial. Diabetes. 67(Supplement_1). 1 indexed citations
7.
Harper, Roy, et al.. (2016). Dynamics in insulin requirements and treatment safety. Journal of Diabetes and its Complications. 30(7). 1333–1338. 10 indexed citations
8.
Pasquel, Francisco J., Roma Gianchandani, Daniel J. Rubin, et al.. (2016). Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial. The Lancet Diabetes & Endocrinology. 5(2). 125–133. 116 indexed citations
9.
Absood, Afaf, et al.. (2013). Insulin Therapy for Pre-Hyperglycemic Beta-Cell Endoplasmic Reticulum Crowding. PLoS ONE. 8(2). e54351–e54351. 13 indexed citations
10.
Bergenstal, Richard M., et al.. (2012). Can a Tool That Automates Insulin Titration Be a Key to Diabetes Management?. Diabetes Technology & Therapeutics. 14(8). 675–682. 28 indexed citations
11.
Herman, William H., et al.. (2011). The effort required to achieve and maintain optimal glycemic control. Journal of Diabetes and its Complications. 25(5). 283–288. 13 indexed citations
12.
Hodish, Israel, Reshef Tal, Aviv Shaish, et al.. (2009). Systemic administration of radiation-potentiated anti-angiogenic gene therapy against primary and metastatic cancer based on transcriptionally controlled HSV-TK. Cancer Biology & Therapy. 8(5). 435–443. 11 indexed citations
13.
Tal, Reshef, Aviv Shaish, Erez Feige, et al.. (2008). Endothelial-targeted Gene Transfer of Hypoxia-inducible Factor-1α Augments Ischemic Neovascularization Following Systemic Administration. Molecular Therapy. 16(12). 1927–1936. 16 indexed citations
14.
Hodish, Israel, Thomas J. Giordano, Monica N. Starkman, & D.E. Schteingart. (2008). Location of ectopic adrenocortical hormone‐secreting tumors causing Cushing's syndrome in the paranasal sinuses. Head & Neck. 31(5). 699–706. 12 indexed citations
15.
Hodish, Israel & Ariel L. Barkan. (2008). Long-term effects of pegvisomant in patients with acromegaly. Nature Clinical Practice Endocrinology & Metabolism. 4(6). 324–332. 35 indexed citations
16.
Varda‐Bloom, Nira, Israel Hodish, Aviv Shaish, et al.. (2008). Specific Induction of Tumor Neovasculature Death by Modified Murine PPE-1 Promoter Armed with HSV-TK. Pathobiology. 75(6). 346–355. 3 indexed citations
17.
Harats, Dror, Dikla Ben‐Shushan, Hofit Cohen, et al.. (2005). Inhibition of carcinogenesis in transgenic mouse models over-expressing 15-lipoxygenase in the vascular wall under the control of murine preproendothelin-1 promoter. Cancer Letters. 229(1). 127–134. 39 indexed citations
18.
Greenberger, Shoshana, Aviv Shaish, Nira Varda‐Bloom, et al.. (2004). Transcription-controlled gene therapy against tumor angiogenesis. Journal of Clinical Investigation. 113(7). 1017–1024. 35 indexed citations
19.
Greenberger, Shoshana, Aviv Shaish, Nira Varda‐Bloom, et al.. (2004). Transcription-controlled gene therapy against tumor angiogenesis. Journal of Clinical Investigation. 113(7). 1017–1024. 40 indexed citations
20.
Hodish, Israel, et al.. (2000). Reiter's syndrome after intravesical Bacillus Calmette-Guérin therapy for bladder cancer.. PubMed. 2(3). 240–1. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen Waugh Breakdown of academic impact, for papers by F. Sodoyez‐Goffaux Breakdown of academic impact, for papers by Ryosuke Misawa Breakdown of academic impact, for papers by Yukiko Kawasaki Breakdown of academic impact, for papers by Julie Méthot Breakdown of academic impact, for papers by Eiji Ohmura Breakdown of academic impact, for papers by Nadia Tinto Breakdown of academic impact, for papers by M. Dreyer Breakdown of academic impact, for papers by Amanda L. Posgai Breakdown of academic impact, for papers by C. M. Hoogerbrugge
Rankless by CCL
2026